Native rhIGF-1 in IGF-1 Deficiency Chernausek et al., Journal of Clinical Endocrinology & Metabolism (2007) Chernausek and colleagues conducted the pivotal long-term clinical trial of recombinant human IGF-1 (mecasermin) in pediatric patients with severe primary IGF-1 deficiency the trial that supported FDA approval of Increlex for this rare growth-failure population
9.1 Food allergy The flowers of Impatiens textori were investigated for their anti-allergic properties, as the 35% ethanol extract demonstrated a decrease in blood pressure and exogenous platelet activating factor, which are hallmarks of allergy-mediated anaphylaxis, inflammation, and pruritus [133]
The exact frequency depends on factors like body weight, treatment goals, and medical advice
P., Swewczyk, M., Kennedy, S., Trush, V